# Trade Mark Journal No.2025/051 19 December 2025

## WO0000001889190 (5,42)

Office of origin: United States of America

Date of International Registration:7 November 2025
Date of designation in the UK: 7 November 2025

International priority date claimed: 20 May 2025 (United States of America) (99194762)

Class 5
  Pharmaceutical products.
Class 42
  Pharmaceutical research and development.

Exelixis, Inc.

Representative: Anessa Kramer Honigman LLP, 39400 Woodward Avenue, Suite 101, Bloomfield Hills MI 48304-5151, UNITED STATES OF AMERICA